We are sector agnostic and focus on high growth opportunities with proven business models that require growth capital. In the last 5 years we have raised over $50m in Equity, and have backed 3 deals and worked closely with management to drive growth, and in that timeframe: Tech - took from $13m in rev to $40m in rev Biotech - took from $3m EV to $200m EV today (Nasdaq listed) Manufacturing - from $1m EBITDA to currently tracking $15M EBITDA We have substantial deal flow and are seeking capital partners to enable us to pursue additional portfolio opportunities.